Traitement actuel de la polyarthrite rhumatoïde

Carli, P.; Landais, C.; Aletti, M.; Cournac, J.-M.; Poisnel, É.; Paris, J.F.

doi:10.1016/j.revmed.2009.08.002

Cited by 10 publications

(3 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Classically, numerous arguments plead for an early diagnosis of RP. Effectively, osteocartilaginous destructions appear early in the evolution of the disease (10% to 15% of the RP have erosions after three months of evolution, 30% after one year, 70% after three years and 95% after six years) and they are irreversible [2]. At our patient, the diagnosis of RP was able to be retained in spite of the absence of arthritis, thanks to the rather specific extra-articular appearances of the disease.…”

Section: Discussionmentioning

confidence: 57%

A seropositive nodular rheumatoid polyarthritis without arthritis, does it exist?

Fatma¹,

Rezgui²,

Karmani³

et al. 2013

OJIM

View full text Add to dashboard Cite

Introduction: The rheumatoid polyarthritis is the most frequent chronic polyarthritis. It affects essentially woman between 40 and 60 years old. Rheumatic subcutaneous nodules and tenosynovitis are usually associated with seropositive symptomatic rheumatoid polyarthritis. However, it is rare that they constitute the essential clinical expression of the disease. Case report: A 60-year-old woman was hospitalized for tumefaction of the dorsal face of the right hand evolved two months before. The clinical examination was found isolated subcutaneous nodules. The anatomopathological exam of one nodule ended in its rheumatoid origin and the MRI of a second one confirmed a tenosynovitis. Anti-CCP antibodies were positive. The patient has never suffered from arthralgias. The evolution was favourable under corticosteroid therapy, methotrexate and colchicine. Discussion: Rheumatic subcutaneous nodules and tenosynovitis are usually associated with seropositive symptomatic rheumatoid polyarthritis. It is rare that they constitute the essential clinical expression of the disease. Conclusion: The extra-articular appearances of the rheumatoid polyarthritis must not be underestimated especially since they can constitute—even rarely—the essential clinical expression of the disease.

show abstract

Section: Discussionmentioning

confidence: 57%

A seropositive nodular rheumatoid polyarthritis without arthritis, does it exist?

Fatma¹,

Rezgui²,

Karmani³

et al. 2013

OJIM

View full text Add to dashboard Cite

show abstract

“…Effectively, osteocartilaginous destructions appear early in the evolution of the disease (10 to 15% of the RP have erosions after three months of evolution, 30% after one year, 70% after three years, and 95% after six years), and they are irreversible [3]. At our patient, the diagnosis of RP was able to be retained in spite of the absence of arthritis, thanks to the rather specific extra-articular appearances of the disease.…”

Section: Discussionmentioning

confidence: 79%

A Seropositive Nodular Rheumatoid Polyarthritis without Arthritis: Does It Exist?

Ismail

Rezgui

Karmani

et al. 2012

Case Reports in Medicine

View full text Add to dashboard Cite

The rheumatoid polyarthritis is the most frequent chronic polyarthritis. It affects essentially the woman between 40 and 60 years. Rheumatic subcutaneous nodules and tenosynovitis are usually associated with seropositive symptomatic rheumatoid polyarthritis. It is, however, rare that they constitute the essential clinical expression of the disease. In this case, it makes dispute another exceptional form of rheumatoid arthritis such as rheumatoid nodulosis. A 60-year-old woman was hospitalized for tumefaction of the dorsal face of the right hand evolving two months before. The clinical examination found subcutaneous nodules from which the exploration ended in rheumatoid nodules with tenosynovitis. The evolution after four years was favourable under corticosteroid therapy, methotrexate, and colchicine.

show abstract

“…It is recognized that corticosteroid therapy and sickle cell anemia increase the risk of infection and osteonecrosis [10,12]. According to the literature, methotrexate is the anchoring treatment for rheumatoid arthritis [13]. Despite the anemia in our patient, treatment with methotrexate was started.…”

Section: Case Presentationmentioning

confidence: 74%

Rheumatoid arthritis in a sickle cell patient: a dangerous association?

Diakité¹,

Traoré

Touré

et al. 2021

jimsa

View full text Add to dashboard Cite

Introduction - The diagnosis of rheumatoid arthritis remains a challenge because sickle cell disease can result in various rheumatological manifestations, including joint and bone pain. The concomitant presence of rheumatoid arthritis and sickle cell disease makes the therapeutic management of both conditions problematic. Observation - A 24-year-old man, a nurse by profession, has been followed for 10 years for homozygous sickle cell disease at the Sickle Cell Disease Research Center (CRLD) of Bamako, Mali. He has presented for 8 months symmetrical polyarthritis with morning stiffness of 3 hours, distinct from the usual vaso-occlusive crisis. The Analog Visual Scale was estimated at 80/100. He reported unquantified weight loss and asthenia. The physical examination showed a deformity in bilateral ulnar deviation, flexion of the right elbow, twelve painful joints, and five swollen joints. Normochromic normocytic anemia (hemoglobin 8.3g/dl), inflammatory syndrome with C - Reactive Protein (CRP) 130.91 mg, and Sedimentation Rate (ESR) 72mm at the first hour were noted. Rheumatoid Factor was weakly positive at 21.3 IU and Anti Citrullinated Peptide Antibodies at 385.2 IU. The radiography discovered bilateral erosive carpets without associated tarsitis and osteonecrosis of both femoral heads. The diagnosis of a very active immunopositive erosive rheumatoid arthritis meeting the criteria of ACR / EULAR 2010 was retained. A treatment based on prednisone 10 mg per day was initiated, associated with methotrexate at a dosage of 15 mg weekly in single-dose, folic acid, calcium, and vitamin D. Conclusion - The coexistence of rheumatoid arthritis in sickle cell patients makes the diagnosis of polyarthritis difficult.

show abstract

Traitement actuel de la polyarthrite rhumatoïde

Cited by 10 publications

References 78 publications

A seropositive nodular rheumatoid polyarthritis without arthritis, does it exist?

A seropositive nodular rheumatoid polyarthritis without arthritis, does it exist?

A Seropositive Nodular Rheumatoid Polyarthritis without Arthritis: Does It Exist?

Rheumatoid arthritis in a sickle cell patient: a dangerous association?

Contact Info

Product

Resources

About